Companies Extend Collaboration as DJI Joins 'Thermal by FLIR' Thermal Innovation Program 

WILSONVILLE, Ore.-Thursday, March 29th 2018 [ AETOS Wire ]

(BUSINESS WIRE) -- FLIR Systems, Inc. (NASDAQ: FLIR) today announced that DJI, the world’s leader in civilian drones and aerial imaging, will integrate a FLIR thermal imaging sensor technology into its new DJI Zenmuse XT2 drone camera. The DJI Zenmuse XT2, DJI’s first dual-sensor and its most advanced gimbal-stabilized camera for commercial drone applications, furthers the collaboration between FLIR® and DJI. The Zenmuse XT2 also joins the ‘Thermal by FLIR’ partner program, which FLIR created to fuel thermal innovation and allow partners to leverage the leadership, quality, and innovation that FLIR’s brand represents in the thermal imaging space.

Built with industrial and public safety applications in mind, the DJI Zenmuse XT2 expands upon the benefits in the f ... Read more »

Driving business performance by building and benchmarking world-class product development capabilities

PITTSBURGH-Thursday, March 29th 2018 [ AETOS Wire ]

(BUSINESS WIRE) -- Building capability to consistently deliver solutions with speed to market, agility, customer satisfaction, and uncompromising quality are all table stakes in today’s competitive business world. The CMMI Institute has released CMMI Development V2.0, a globally recognized process improvement model of software, product and systems development best practices that will elevate organizational performance.

“Global adoption of the CMMI has been growing at a record rate because of the material results it delivers,” said Kirk Botula, CMMI Institute CEO. “High-performance commercial and government organizations around the world rely on CMMI to provide a clear roadmap to mitigate risk, create value, and build a resilient culture of continuous improvement. These include compan ... Read more »

INGELHEIM, Germany-Thursday, March 29th 2018 [ AETOS Wire ]

    Results enhance existing evidence base showing Spiolto® Respimat® improves symptom reduction and quality of life over Spiriva® Respimat®2,3,4,5,6

For media excluding the United States of America, Canada and the United Kingdom

(BUSINESS WIRE) -- Boehringer Ingelheim today announced data from the landmark 52-week DYNAGITO® trial which show that in people with COPD (chronic obstructive pulmonary disease), Spiolto® Respimat® (tiotropium/olodaterol 5/5µg) lowers the rate of moderate-to-severe exacerbations compared with Spiriva® Respimat® (tiotropium). The pre-specified significance level of p<0.01 for the primary endpoint of DYNAGITO® was not met.1 Treatment with tiotropium/olodaterol resulted in a 7% lower rate of moderate-to-severe COPD exacerbations compared with tiotropium alone (p=0.0498).1 This study, involving more than 7,800 peop ... Read more »